Beyond their potential use in preventing metastases in early stages of cancer, the evidence suggesting that AXL activity can keep the disseminated tumor cells dormant could provide a way to eliminate disseminated cells by making them less resistant to other therapies. The gene discussed is AXL; the disease is cancer.